Voyager Therapeutics is trading at $3.25 (5.2% up) in pre-market, rebounding from several mixed sessions over the past week despite a lack of fresh company-specific news.
- The move comes in the absence of new analyst calls, regulatory updates, or headlines, suggesting the gain may be driven by light pre-market liquidity.
- A mildly firmer overall equity tone is likely contributing to the upward movement as the stock recovers from recent volatility.